CN104487434B - 双环取代的嘧啶类化合物 - Google Patents
双环取代的嘧啶类化合物 Download PDFInfo
- Publication number
- CN104487434B CN104487434B CN201380039519.4A CN201380039519A CN104487434B CN 104487434 B CN104487434 B CN 104487434B CN 201380039519 A CN201380039519 A CN 201380039519A CN 104487434 B CN104487434 B CN 104487434B
- Authority
- CN
- China
- Prior art keywords
- pyrimidine
- chloro
- group
- compound
- methoxybenzylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC1CCN(*)CC1 Chemical compound CC1CCN(*)CC1 0.000 description 26
- LVWXBAYQHFPLSO-BSIYMUDXSA-N CC/C(/C=C\CC(F)(F)F)=C/C=C Chemical compound CC/C(/C=C\CC(F)(F)F)=C/C=C LVWXBAYQHFPLSO-BSIYMUDXSA-N 0.000 description 1
- SQIOKIUOUDQCCQ-UHFFFAOYSA-O CCc(cc1)cc2c1OCC[NH2+]2 Chemical compound CCc(cc1)cc2c1OCC[NH2+]2 SQIOKIUOUDQCCQ-UHFFFAOYSA-O 0.000 description 1
- NRGGMCIBEHEAIL-UHFFFAOYSA-N CCc1ncccc1 Chemical compound CCc1ncccc1 NRGGMCIBEHEAIL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201380039519.4A CN104487434B (zh) | 2012-08-14 | 2013-08-14 | 双环取代的嘧啶类化合物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102891853 | 2012-08-14 | ||
| CN201210289185 | 2012-08-14 | ||
| CN201380039519.4A CN104487434B (zh) | 2012-08-14 | 2013-08-14 | 双环取代的嘧啶类化合物 |
| PCT/CN2013/000953 WO2014026467A1 (zh) | 2012-08-14 | 2013-08-14 | 双环取代的嘧啶类化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104487434A CN104487434A (zh) | 2015-04-01 |
| CN104487434B true CN104487434B (zh) | 2018-05-22 |
Family
ID=50101233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380039519.4A Active CN104487434B (zh) | 2012-08-14 | 2013-08-14 | 双环取代的嘧啶类化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9359371B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2886540B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6037489B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101794321B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104487434B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015003232B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2641992T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014026467A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014154168A1 (zh) * | 2013-03-29 | 2014-10-02 | 山东轩竹医药科技有限公司 | 双环取代的嘧啶类pde-5抑制剂的前药 |
| CN111406053B (zh) * | 2017-12-11 | 2023-03-31 | 轩竹生物科技股份有限公司 | 磷酸二酯酶-5抑制剂的晶型 |
| CN109438421A (zh) * | 2018-11-13 | 2019-03-08 | 扬州市三药制药有限公司 | 一种阿伐那非中间体的精制纯化方法 |
| WO2020177128A1 (zh) * | 2019-03-07 | 2020-09-10 | 华东理工大学 | 2,6-二氮杂螺[3.4]辛烷类嘧啶-异羟肟酸化合物及其用途 |
| WO2020177129A1 (zh) * | 2019-03-07 | 2020-09-10 | 华东理工大学 | 2,7-二氮杂-螺[4.4]壬烷类异羟肟酸嘧啶类化合物及其制备和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2383466C (en) | 1999-09-16 | 2009-08-25 | Tanabe Seiyaku Co., Ltd. | Aromatic nitrogen-containing 6-membered cyclic compounds |
| JP3637961B2 (ja) * | 1999-09-16 | 2005-04-13 | 田辺製薬株式会社 | 芳香族含窒素六員環化合物 |
| ATE314362T1 (de) | 1999-10-12 | 2006-01-15 | Takeda Pharmaceutical | Pyrimidin-5-carboximidverbindungen, verfahren zur herstellung derselben und deren verwendung |
| JP2001233875A (ja) * | 1999-10-12 | 2001-08-28 | Takeda Chem Ind Ltd | ピリミジン−5−カルボキサミド化合物、その製造法およびその用途 |
| KR100711042B1 (ko) | 2000-04-28 | 2007-04-24 | 다나베 세이야꾸 가부시키가이샤 | 환상 화합물 |
| ES2381862T3 (es) | 2000-09-06 | 2012-06-01 | Mitsubishi Tanabe Pharma Corporation | Preparaciones para administración por vía oral |
| JP4178816B2 (ja) * | 2001-03-15 | 2008-11-12 | 田辺三菱製薬株式会社 | 医薬組成物 |
| US20080070930A1 (en) | 2006-08-24 | 2008-03-20 | Huang Kenneth H | Pyrimidine and Pyrazine Derivatives |
| BRPI0910668A2 (pt) | 2008-04-22 | 2019-09-24 | Portola Pharmaceutiacals Inc | inibidores de proteína quinases |
| CN102372697A (zh) * | 2010-08-19 | 2012-03-14 | 山东轩竹医药科技有限公司 | 取代的嘧啶类化合物 |
| JP2013544829A (ja) * | 2010-11-24 | 2013-12-19 | エクセリクシス, インク. | PI3K/mTORの阻害剤としてのベンゾオキサゼピンおよびその使用と製造方法 |
| US8980904B2 (en) | 2011-07-21 | 2015-03-17 | Xuanzhu Pharma Co., Ltd. | Heterocyclic substituted pyrimidine compound |
-
2013
- 2013-08-14 EP EP13829720.5A patent/EP2886540B1/en active Active
- 2013-08-14 JP JP2015526856A patent/JP6037489B2/ja active Active
- 2013-08-14 WO PCT/CN2013/000953 patent/WO2014026467A1/zh not_active Ceased
- 2013-08-14 US US14/421,703 patent/US9359371B2/en active Active
- 2013-08-14 KR KR1020157006568A patent/KR101794321B1/ko active Active
- 2013-08-14 BR BR112015003232A patent/BR112015003232B1/pt active IP Right Grant
- 2013-08-14 CN CN201380039519.4A patent/CN104487434B/zh active Active
- 2013-08-14 ES ES13829720.5T patent/ES2641992T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104487434A (zh) | 2015-04-01 |
| EP2886540B1 (en) | 2017-07-26 |
| ES2641992T3 (es) | 2017-11-14 |
| KR20150042846A (ko) | 2015-04-21 |
| EP2886540A4 (en) | 2015-06-24 |
| BR112015003232B1 (pt) | 2020-04-07 |
| WO2014026467A1 (zh) | 2014-02-20 |
| HK1205738A1 (en) | 2015-12-24 |
| BR112015003232A2 (pt) | 2017-10-24 |
| US9359371B2 (en) | 2016-06-07 |
| US20150232474A1 (en) | 2015-08-20 |
| EP2886540A1 (en) | 2015-06-24 |
| KR101794321B1 (ko) | 2017-12-01 |
| JP6037489B2 (ja) | 2016-12-07 |
| JP2015524828A (ja) | 2015-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4031547B1 (en) | Plasma kallikrein inhibitors and uses thereof | |
| EP3753941B1 (en) | Pyrimidine-fused cyclic compound, preparation method therefor and application thereof | |
| CN102971317B (zh) | 四氢-吡啶并-嘧啶衍生物 | |
| US9233977B2 (en) | Leucine-rich repeat kinase enzyme activity | |
| AU2020220225A1 (en) | Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof | |
| JP2020515538A (ja) | Shp2阻害剤として有用な新規な複素環式誘導体 | |
| BR112016023117B1 (pt) | Compostos de heteroarila ou arila bicíclicos fundidos | |
| US9926318B2 (en) | Tetracyclic autotaxin inhibitors | |
| WO2019062733A1 (zh) | Pde9 抑制剂及其用途 | |
| CN105777756A (zh) | 杂芳化合物及其在药物中的应用 | |
| AU2009242248A1 (en) | Imidazolidinone derivatives as 11b-HSD1 inhibitors | |
| WO2024220866A1 (en) | Novel aminopyrimidine derivatives as cyclin-dependent kinase inhibitors | |
| JP2024505711A (ja) | 窒素含有多環式縮合環系化合物、その医薬組成物、製造方法及び用途 | |
| WO2017156177A1 (en) | 3-phosphoglycerate dehydrogenase inhibitors and uses thereof | |
| CA3056501A1 (en) | Fluorine-substituted indazole compounds and uses thereof | |
| KR101794321B1 (ko) | 바이사이클릭 그룹 치환된 피리미딘 화합물 | |
| KR20250175338A (ko) | Tyk2 분해제 및 이의 용도 | |
| CN115697972A (zh) | 包括哌嗪杂环酰胺脲的受体-相互作用蛋白1抑制剂 | |
| ES2532902T3 (es) | Piridil-vinil-pirroles tricíclicos como inhibidores de PAR1 | |
| EP4556477A1 (en) | Tgf-beta inhibitor compound and use thereof | |
| CN105579459B (zh) | 四并环类间变性淋巴瘤激酶抑制剂 | |
| WO2024227033A1 (en) | Heterocyclic compounds as parp1 inhibitors | |
| HK1205738B (en) | Bicyclic substituted pyrimidine compounds | |
| HK40074859B (en) | Plasma kallikrein inhibitors and uses thereof | |
| HK40074859A (en) | Plasma kallikrein inhibitors and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190123 Address after: 570105 Tianyi International Building, 85 Binhai Avenue, Longhua District, Haikou City, Hainan Province, 27th Floor Patentee after: Hainan Xuanzhu Pharma Co.,Ltd. Address before: 250101 No. 2518 Tianchen Street, Jinan High-tech Zone, Shandong Province Patentee before: XUANZHU PHARMA Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 570105 Tianyi International Building, 85 Binhai Avenue, Longhua District, Haikou City, Hainan Province, 27th Floor Patentee after: Xuanzhu (Hainan) Pharmaceutical Technology Co.,Ltd. Address before: 570105 Tianyi International Building, 85 Binhai Avenue, Longhua District, Haikou City, Hainan Province, 27th Floor Patentee before: Hainan Xuanzhu Pharma Co.,Ltd. |
|
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 050000 Beijing Tianjin Hebei Collaborative Innovation Demonstration Park, 769 Taihang street, high tech Zone, Shijiazhuang City, Hebei Province 203c507 Patentee after: Xuanzhu Biotechnology Co.,Ltd. Address before: 570105 Tianyi International Building, 85 Binhai Avenue, Longhua District, Haikou City, Hainan Province, 27th Floor Patentee before: Xuanzhu (Hainan) Pharmaceutical Technology Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 050000 Beijing Tianjin Hebei Collaborative Innovation Demonstration Park 203c507, 769 Taihang street, high tech Zone, Shijiazhuang City, Hebei Province Patentee after: Xuanzhu Biotechnology Co.,Ltd. Address before: 050000 Beijing Tianjin Hebei Collaborative Innovation Demonstration Park 203c507, 769 Taihang street, high tech Zone, Shijiazhuang City, Hebei Province Patentee before: Xuanzhu Biotechnology Co.,Ltd. |
|
| EE01 | Entry into force of recordation of patent licensing contract | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150401 Assignee: LIVZON Group LIVZON PHARMACEUTICAL FACTORY Assignor: Xuanzhu Biotechnology Co.,Ltd. Contract record no.: X2024980018509 Denomination of invention: Double ring substituted pyrimidine compounds Granted publication date: 20180522 License type: Exclusive License Record date: 20241015 |